Recently, it was demonstrated that white adipose tissue (WAT) surface expression of LDL receptor (LDLR) and/or CD36 is associated with metabolic dysfunction and insulin resistance, both WAT-directed and systemic [65]. Here, LDLR is linked to Insulin resistance.